UNSPSC 51283804: Volpristin

This classification denotes an antibiotic with the molecular formula C28H37N3O7, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 18UAN5144E. The term VOLPRISTIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 13 no. 3, 1999, list 42. ). SMILES: CC1C=CC(=O)NCC=CC(=CC(CC(=O)CC2=NC(=CO2)C(=O)N3CCC(C3)C(=O)OC1C(C)C)O)C.

UNSPSC 51283804 Volpristin, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The recent opportunities tagged under this code involve pharmaceutical procurement — primarily naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical supplies, and multi-source generic pharmaceuticals — but none of these solicitations appear to solicit volpristin specifically. State and local governments are purchasing naloxone, first-aid supplies, and generic pharmaceuticals through competitive bids and cooperative purchasing vehicles, with issuing bodies including county health departments, state health and human services commissions, municipal fire departments, and multistate cooperative alliances. The work involves establishing supply contracts with multiple authorized distributors, managing expiration-date compliance, meeting cGMP and FDA standards, and in some cases establishing direct relationships between procurement bodies and pharmaceutical manufacturers.

Recent activity spans Florida, Texas, Minnesota, and Oregon through multiple procurement mechanisms. Seminole County, Florida issued IFB 60459723LAS in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, a fixed-fee contract with a two-year initial term and one-year renewal option. The City of Tampa issued IFB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for its Fire Department Rescue Division, a $700,000 estimated contract sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 exploring direct-to-manufacturer prescription fulfillment capabilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 to establish multiple contracts for generic pharmaceuticals and OTC products distributed across Minnesota, Oregon, and other participating jurisdictions, with proposals due March 26, 2026. The code shows sparse and scattered activity with limited direct relevance to volpristin procurement.